Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma

The main treatment modalities for stage III-IV oropharyngeal squamous cell carcinoma (OPSCC) are surgery, radiotherapy (RTx), chemotherapy, or combined therapies. Conventional surgical approaches such as mandibulotomy or composite resection show high morbidity rates associated with treatment and postoperatively induce deterioration of the voice and swallowing function [1,2]. Therefore, concurrent chemoradiotherapy (CCRTx) is mainly used in patients with advanced OPSCC as an organ-preserving strategy.

Source: Oral Oncology - October 21, 2017 Category: Cancer & Oncology Authors: Young Min Park, Hye Ryun Kim, Byoung Chul Cho, Ki Chang Keum, Nam Hoon Cho, Se-Heon Kim Source Type: research